Campbell Fund Trust Reports Unregistered Equity Sales
| Field | Detail |
|---|---|
| Company | Campbell Fund Trust |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $792,400, $3,536,008.48, $300,000.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, unregistered-securities
TL;DR
Campbell Fund Trust sold unregistered equity. Watch for dilution.
AI Summary
On September 30, 2025, Campbell Fund Trust filed an 8-K report detailing unregistered sales of equity securities. The filing, submitted on October 6, 2025, indicates a reportable period ending September 30, 2025. The company is incorporated in Delaware and its principal executive offices are located in Baltimore, Maryland.
Why It Matters
This filing signals potential new equity issuance by Campbell Fund Trust, which could impact existing shareholders through dilution or signal growth initiatives.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes indicate less transparency or potential regulatory scrutiny compared to registered offerings.
Key Players & Entities
- CAMPBELL FUND TRUST (company) — Registrant
- September 30, 2025 (date) — Report date
- October 6, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Baltimore, Maryland (location) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing indicates 'Unregistered Sales of Equity Securities' but does not specify the exact type of securities in the provided text.
Were these sales made to accredited investors?
The filing mentions 'Unregistered Sales of Equity Securities,' which often implies sales to accredited investors or under specific exemptions, but the exact details are not in the provided text.
What is the total value of the unregistered equity sold?
The provided text does not contain information on the dollar amount of the unregistered equity securities sold.
What is the purpose of these unregistered equity sales?
The filing does not specify the purpose behind the unregistered sales of equity securities in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K filing is September 30, 2025.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 14.4 · Accepted 2025-10-06 14:03:54
Key Financial Figures
- $792,400 — nterest, sold on September 30, 2025 was $792,400.00, $3,536,008.48 and $300,000.00 in ca
- $3,536,008.48 — on September 30, 2025 was $792,400.00, $3,536,008.48 and $300,000.00 in cash for Series A, S
- $300,000.00 — 2025 was $792,400.00, $3,536,008.48 and $300,000.00 in cash for Series A, Series D and Seri
Filing Documents
- ef20056706_8k.htm (8-K) — 28KB
- 0001140361-25-037345.txt ( ) — 140KB
- cft-20250930.xsd (EX-101.SCH) — 4KB
- cft-20250930_lab.xml (EX-101.LAB) — 20KB
- cft-20250930_pre.xml (EX-101.PRE) — 14KB
- ef20056706_8k_htm.xml (XML) — 4KB
02
Item 3.02 Effective as of September 30, 2025, Registrant sold equity securities in Registrant ("Units of Beneficial Interest") to existing and/or new unitholders of Registrant in transactions that were not registered under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate estimate consideration for Units of Beneficial Interest, excluding escrow interest, sold on September 30, 2025 was $792,400.00, $3,536,008.48 and $300,000.00 in cash for Series A, Series D and Series W, respectively. The Units of Beneficial Interest were issued by Registrant in reliance upon an exemption from registration under the Securities Act set forth in Section 4(2) of the Securities Act, as transactions not constituting a public offering of securities because the Units of Beneficial Interest were issued privately pursuant to Regulation D.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CAMPBELL FUND TRUST Date: October 6, 2025 By: /s/ Thomas P. Lloyd Thomas P. Lloyd General Counsel and Chief Compliance Officer